Back
ESC Premium Access

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Session: Atrial fibrillation e-posters
Topic: Rhythm Control, Catheter Ablation
Speaker: Associate Professor T. Mine (Hyogo, JP)
Event: ESC Congress 2021 - The Digital Experience

Congress Session

0

About the speaker

Associate Professor Takanao Mine

Hyogo College of Medicine, Hyogo (Japan)
0 follower

160 more presentations in this session

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Access
Abstract
Slides
1
Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Access
Abstract
Slides
0
Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Access
Abstract
Slides
0
Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Access
Abstract
Slides
0
Thumbnail

Outcomes and resource utilization of atrial fibrillation hospitalizations with type 2 myocardial infarction

Speaker: Mr R. Ariss (Toledo, US)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour, Doctor C. Boerschel...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Pregnancy and pulmonary hypertension.

27 August 2021

ESC Premium Access

Comparing Rivaroxaban and Apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria

27 August 2021

ESC Premium Access

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events

27 August 2021

This platform is supported by

logo Novo Nordisk